Yilai Shu

6.5k citations

105 papers · 4.1k indexed · 2 hit papers · h-index 30

Co-authors: Zheng‐Yi Chen David B. Thompson David R. Liu Johnny H. Hu John A. Zuris Morgan L. Maeder John P. Guilinger J. Keith Joung
Topics: Hearing, Cochlea, Tinnitus, Genetics (48 papers)RNA regulation and disease (24 papers)CRISPR and Genetic Engineering (22 papers)
Cited by: Sensory Systems Business and International Management Otorhinolaryngology
Journals: Nature Journal of the American Chemical Society Nature Communications
Partner nations: China United States Finland

In The Last Decade

Yilai Shu

98 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo

2014 1.2k citations John A. Zuris, David B. Thompson et al. profile →
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents

2017 410 citations Xue Gao, Yong Tao et al. profile →

Peers

Countries citing papers authored by Yilai Shu

Since Specialization

Citations

This map shows the geographic impact of Yilai Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yilai Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yilai Shu more than expected).

Fields of papers citing papers by Yilai Shu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yilai Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yilai Shu. The network helps show where Yilai Shu may publish in the future.

Co-authorship network of co-authors of Yilai Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Yilai Shu. A scholar is included among the top collaborators of Yilai Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yilai Shu. Yilai Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Audiological characteristics following gene therapy in patients with autosomal recessive deafness 9 2025 ·Med ·Longlong Zhang,(unknown),Yanbo Yin,(unknown),(unknown),Qi Cao,Wuqing Wang,Bing Chen,(unknown),Huawei Li,Daqi Wang,Yilai Shu	2
2	Comparative analysis of RNA versus protein splicing in dual AAV-mediated gene therapy in a mouse model of DFNB9 deafness 2025 ·Molecular Therapy ·(unknown),(unknown),Hui Wang,Jingjing Zhao,Guotao Tang,(unknown),Shaowei Hu,Longlong Zhang,Daqi Wang,Yuxin Chen,Jianping Liu,Honghai Tang,Geng‐Lin Li,Bing Chen,Yilai Shu	0
3	Prevalence and spectrum of STRC variants in 1015 sensorineural hearing loss patients: insights from the Chinese population 2025 ·Molecular Genetics and Genomics ·Luo Guo,Sha Yu,Wenrui Zhao,(unknown),(unknown),Weitao Li,Wei Li,(unknown),Shan Sun,(unknown),Haiying Liu,(unknown),Huawei Li,Yilai Shu	0
4	Mechanisms and otoprotective strategies of programmed cell death on aminoglycoside-induced ototoxicity 2024 ·Frontiers in Cell and Developmental Biology ·Lei Han,Zijing Wang,Daqi Wang,Ziwen Gao,Shaowei Hu,(unknown),Yilai Shu	7
5	Hair cell-specific Myo15 promoter-mediated gene therapy rescues hearing in DFNB9 mouse model 2024 ·Molecular Therapy — Nucleic Acids ·Hui Wang,(unknown),Honghai Tang,Jingjing Zhao,Shaowei Hu,Longlong Zhang,Jun Lv,Daqi Wang,Yuxin Chen,Jianping Liu,Geng‐Lin Li,Wuqing Wang,Yilai Shu,Huawei Li	15
6	Nanobiomaterial vectors for improving gene editing and gene therapy 2023 ·Materials Today ·(unknown),Tao Ding,Honghai Tang,(unknown),Wenguo Cui,Yilai Shu	37
7	The pathogenesis of common Gjb2 mutations associated with human hereditary deafness in mice 2023 ·Cellular and Molecular Life Sciences ·Qing Li,Chong Cui,(unknown),(unknown),Daqi Wang,Yanbo Cheng,(unknown),(unknown),Meng Yan,(unknown),Jingjing Zhao,Wei Tang,Yingyi Wang,(unknown),Jun Lv,Jinsong Li,Huawei Li,Yilai Shu	9
8	Novel heterozygous USH1C mutation impacts hair cell mechanotransduction and causes progressive hearing loss 2023 ·Science Bulletin ·Yanyan Jia,(unknown),Luo Guo,Nan Song,(unknown),Luoying Jiang,Yilai Shu,Yan Chen,Shujia Zhu,Huawei Li,Wenyan Li	3
9	Asymmetric pendrin homodimer reveals its molecular mechanism as anion exchanger 2023 ·Nature Communications ·(unknown),Xiang Zhang,(unknown),Yuxin Chen,Fang Wang,(unknown),Wuqiang Zhan,(unknown),Yuxia Hu,(unknown),Yifang Sun,Meng Zhang,(unknown),Geng‐Lin Li,Weijia Zhang,Yilai Shu,Lei Sun,Zhenguo Chen	18
10	Advances in gene therapy hold promise for treating hereditary hearing loss 2023 ·Molecular Therapy ·Luoying Jiang,Daqi Wang,Yingzi He,Yilai Shu	63
11	Preclinical evaluation of the efficacy and safety of AAV1-hOTOF in mice and nonhuman primates 2023 ·Molecular Therapy — Methods & Clinical Development ·Longlong Zhang,(unknown),(unknown),(unknown),Jinghan Wang,(unknown),Biyun Zhu,Yuxin Chen,Daqi Wang,(unknown),Ziwen Gao,Jianping Liu,Zhengyi Chen,Bing Chen,Huawei Li,Yilai Shu	21
12	Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo 2023 ·Nature Communications ·Yong Tao,Verónica Lamas,Wan Du,Wenliang Zhu,Yiran Li,Madelynn N. Whittaker,John A. Zuris,David B. Thompson,Arun Prabhu Rameshbabu,Yilai Shu,Xue Gao,Johnny H. Hu,(unknown),Weijia Kong,Xuezhong Liu,Hao Wu,Benjamin P. Kleinstiver,David R. Liu,Zheng‐Yi Chen	29
13	Precise detection of CRISPR-Cas9 editing in hair cells in the treatment of autosomal dominant hearing loss 2022 ·Molecular Therapy — Nucleic Acids ·Chong Cui,Daqi Wang,(unknown),Fang Wang,Yuxin Chen,Jun Lv,Luping Zhang,Lei Han,Dong Liu,Zheng‐Yi Chen,Geng‐Lin Li,Huawei Li,Yilai Shu	36
14	Microfluidic Preparation of Gelatin Methacryloyl Microgels as Local Drug Delivery Vehicles for Hearing Loss Therapy 2022 ·ACS Applied Materials & Interfaces ·Jiali Wang,Chong Wang,Qiao Wang,Zhuohao Zhang,Hui Wang,(unknown),(unknown),Luoran Shang,Wuqing Wang,Yilai Shu	34
15	PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest 2022 ·Nature Communications ·(unknown),Chenwei Wang,Xuran Zhuang,Shaofeng Lin,Miaomiao Luo,Wankun Deng,Jiaqi Zhou,Lihui Liu,Lina Mao,Wenbo Peng,Jian Chen,Qiangsong Wang,Yilai Shu,Yu Xue,Pengyu Huang	11
16	Specific knockdown of Htra2 by CRISPR-CasRx prevents acquired sensorineural hearing loss in mice 2022 ·Molecular Therapy — Nucleic Acids ·Yang Guo,Lei Han,Shuang Han,Honghai Tang,Shengyi Wang,Chong Cui,Bing Chen,Huawei Li,Yilai Shu	16
17	Rescue of mis-splicing of a common SLC26A4 mutant associated with sensorineural hearing loss by antisense oligonucleotides 2022 ·Molecular Therapy — Nucleic Acids ·(unknown),Zhijiao Xu,Jialin Chen,Meizhen Liu,Yu Zhao,Daqi Wang,Lei Han,(unknown),Bo Wan,Xingshun Xu,Dali Li,Yilai Shu,Yimin Hua	13
18	Prevention of acquired sensorineural hearing loss in mice by in vivo Htra2 gene editing 2021 ·Genome biology ·Xi Gu,Daqi Wang,Zhijiao Xu,Jinghan Wang,Luo Guo,Renjie Chai,(unknown),Yilai Shu,Huawei Li	43
19	Clinical Characteristics of Patients With Papilloma in the External Auditory Canal 2020 ·The Laryngoscope ·(unknown),(unknown),Kevin A. Peng,(unknown),Qiang Du,(unknown),Chunfu Dai,Fanglu Chi,Yilai Shu	2
20	The Benefits of Residual Hair Cell Function for Speech and Music Perception in Pediatric Bimodal Cochlear Implant Listeners 2018 ·Neural Plasticity ·Xiaoting Cheng,(unknown),(unknown),Y. Yuan,John J. Galvin,Qian‐Jie Fu,Yilai Shu,Bing Chen	22

About Yilai Shu

Yilai Shu is a scholar working on Sensory Systems, Otorhinolaryngology and Neurology, having authored 105 papers that have together received 4.1k indexed citations. Recurring topics across this work include Hearing, Cochlea, Tinnitus, Genetics (48 papers), RNA regulation and disease (24 papers) and CRISPR and Genetic Engineering (22 papers). The work is most often cited by research in Sensory Systems (1.2k citations), Business and International Management (143 citations) and Otorhinolaryngology (208 citations). Yilai Shu has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Zheng‐Yi Chen, David B. Thompson, David R. Liu, Johnny H. Hu, John A. Zuris, Morgan L. Maeder, John P. Guilinger, J. Keith Joung, Huawei Li and Yong Tao. Their work appears in journals such as Nature, Journal of the American Chemical Society and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact